MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH

被引：0
|
作者：
Beaton, Michelle
Guionaud, Silvia
Conway, James P.
Grimsby, Joe
Rhodes, Christopher J.
Jermutus, Lutz
Trevaskis, James
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efruxifermin combined with a GLP-1 receptor agonist reduces liver fat in NASH
    Thiago Carvalho
    Nature Medicine, 2023, 29 : 1881 - 1881
  • [32] Efruxifermin combined with a GLP-1 receptor agonist reduces liver fat in NASH
    Carvalho, Thiago
    NATURE MEDICINE, 2023, 29 (08) : 1881 - 1881
  • [33] GLP-1/glucagon dual receptor agonist ALT-801 is superior to semaglutide in improving NASH endpoints in a biopsy-confirmed DIO mouse model
    Nestor, John
    Rigbolt, Kristoffer
    Feigh, Michael
    Parkes, David
    Harris, M. Scott
    JOURNAL OF HEPATOLOGY, 2020, 73 : S456 - S456
  • [34] Effect of Pemvidutide, a GLP-1/Glucagon Dual Receptor Agonist, on Cardioinflammatory Lipids
    Suschak, John J.
    Georges, Bertrand
    Roberts, M. S.
    Harris, M. Scott
    Browne, Sarah K.
    DIABETES, 2024, 73
  • [35] Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
    Nestor, John J.
    Parkes, David
    Feigh, Michael
    Suschak, John
    Harris, M. Scott
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [36] Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
    John J. Nestor
    David Parkes
    Michael Feigh
    John J. Suschak
    M. Scott Harris
    Scientific Reports, 12
  • [37] A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor (vol 20, 3532, 2019)
    Al-Zamel, Noura
    Al-Sabah, Suleiman
    Luqmani, Yunus
    Adi, Lobna
    Chacko, Siby
    Schneider, Tom Dario
    Krasel, Cornelius
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [38] MEDI0382 a novel GLP1/glucagon co-agonist induces profound body weight loss and improves metabolism in rodents and non-human primates
    Konkar, A.
    Ambery, P.
    Bednarek, M.
    Fritsch-Fredin, M.
    Grimsby, J.
    Henderson, S.
    Hornigold, D.
    Jackson, R.
    Rondinone, C.
    Trevaskis, J.
    Jermutus, L.
    DIABETOLOGIA, 2015, 58 : S310 - S310
  • [39] Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of and Diabetes
    Palani, Anandan
    Nawrocki, Andrea R.
    Orvieto, Federica
    Bianchi, Elisabetta
    Mandic, Emanuela
    Pessi, Antonello
    Huang, Chunhui
    Deng, Qiaolin
    Toussaint, Nathalie
    Walsh, Erika
    Reddy, Vijay
    Ashley, Eric
    He, Huaibing
    Mumick, Sheena
    Hawes, Brian
    Marsh, Donald
    Erion, Mark
    Nargund, Ravi
    Carrington, Paul E.
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (08): : 1248 - 1254
  • [40] Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide
    Shweta Urva
    Tonya Quinlan
    John Landry
    Xiaosu Ma
    Jennifer A. Martin
    Charles T. Benson
    Clinical Pharmacokinetics, 2022, 61 : 1057 - 1067
12345